US EditionPublished • loading... • Updated
Merit Medical Provides Update on U.S. Reimbursement and Commercial Strategies for WRAPSODY® Cell-Impermeable Endoprosthesis
Summary by The Manila Times
1 Articles
1 Articles
Merit Medical Provides Update on U.S. Reimbursement and Commercial Strategies for WRAPSODY® Cell-Impermeable Endoprosthesis
SOUTH JORDAN, Utah, Nov. 13, 2025 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader of healthcare technology, announced today that the U.S. Centers for Medicare & Medicaid Services ('CMS”) has notified Merit that its application for Transitional Pass-Through ('TPT”) incremental payment for WRAPSODY® Cell-Impermeable Endoprosthesis ('CIE”) procedures in the outpatient and ambulatory surgery center ('ASC”) settings re…
·Manila, Philippines
Read Full ArticleCoverage Details
Total News Sources1
Leaning Left0Leaning Right1Center0Last UpdatedBias Distribution100% Right
Bias Distribution
- 100% of the sources lean Right
100% Right
R 100%
Factuality
To view factuality data please Upgrade to Premium
